What are the rates of noncompliance among patients with different types of cancer?
For example, are patients with breast cancer more or less compliant than patients with non-Hodgkin’s disease or lung cancer? Or are noncompliance rates typically equal among all cancer patients, no matter what type? At URA Rx, we work with oncology patients across all indications. Non-adherence with prescribed regimens is a problem common to all cancers and all ages, ranging from adolescents being treated for leukemia to older adults undergoing treatment for a variety of cancers. There are more reports in the literature on non-adherence to breast cancer than other types of cancer, but that is likely due to the high incidence of breast cancer and the large number of oral regimens used to treat this common cancer. When we at URA RX look at adherence studies across disease types, the rates of non-adherence range from 0% to 80%. One issue that contributes to increased non-adherence over time is the increased number of maintenance, or long-term treatment regimens. Long-term regimens have be
